We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

129 hedge funds and large institutions have $2.05B invested in Ironwood Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 45 increasing their positions, 42 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

157% more call options, than puts

Call options by funds: $1.77M | Put options by funds: $688K

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

20% more capital invested

Capital invested by funds: $1.71B → $2.05B (+$337M)

7% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 42

8% less funds holding

Funds holding: 140 → 129 (-11)

47% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 19

Holders
129
Holders Change
-11
Holders Change %
-7.86%
% of All Funds
3.44%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.11%
New
10
Increased
45
Reduced
42
Closed
19
Calls
$1.77M
Puts
$688K
Net Calls
+$1.08M
Net Calls Change
+$5.39M

Top Buyers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
+$22.6M
2
Millennium Management
Millennium Management
New York
+$18.2M
3
JHIU
Janus Henderson Investors US
Colorado
+$16.9M
4
SAM
Senzar Asset Management
New York
+$10.7M
5
BFA
BlackRock Fund Advisors
California
+$7.62M

Top Sellers

Rank Fund Capital Flow
1
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$15.6M
2
Fidelity International
Fidelity International
Bermuda
-$10.7M
3
CCP
Clough Capital Partners
Massachusetts
-$8.17M
4
CGT
Capital Guardian Trust
California
-$7.41M
5
VAM
Visium Asset Management
New York
-$7.13M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$11M +$240K +20,951 +3%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$9.78M +$433K +37,864 +5%
EAM
28
EverPoint Asset Management
Connecticut
$7.66M +$4.44M +388,050 +186%
Axa
29
Axa
France
$7.15M -$3.43M -299,822 -35%
RNS
30
Robert N. Shapiro
$7.13M -$278K -24,274 -4%
TCIM
31
TIAA CREF Investment Management
New York
$6.69M -$331K -28,884 -5%
LOAMU
32
Lombard Odier Asset Management (USA)
New York
$6.23M +$1.12M +97,563 +25%
BBA
33
Baker Bros. Advisors
New York
$5.3M – – –
GC
34
Guggenheim Capital
Illinois
$5.14M +$384K +33,512 +9%
Thrivent Financial for Lutherans
35
Thrivent Financial for Lutherans
Minnesota
$5.05M -$107K -9,313 -2%
FM
36
Forward Management
California
$5.02M +$1.73M +150,893 +52%
Charles Schwab
37
Charles Schwab
California
$4.98M +$158K +13,823 +4%
BIM
38
BlackRock Investment Management
Delaware
$4.97M -$44.3K -3,870 -1%
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$4.39M +$396K +34,608 +12%
Allianz Asset Management
40
Allianz Asset Management
Germany
$4.19M +$1.63M +142,534 +77%
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$3.4M -$504K -43,997 -14%
AG
42
Artal Group
Luxembourg
$3.32M – – –
AllianceBernstein
43
AllianceBernstein
Tennessee
$3.19M – – –
TRSOTSOK
44
Teachers Retirement System of the State of Kentucky
Kentucky
$2.96M – – –
PAM
45
Paradigm Asset Management
New York
$2.92M +$133K +11,582 +5%
TA
46
Teachers Advisors
New York
$2.79M – – –
BCB
47
Brian C. Broderick
$2.49M -$54.7K -4,776 -2%
Wells Fargo
48
Wells Fargo
California
$2.33M +$196K +17,093 +10%
NFA
49
Nationwide Fund Advisors
Ohio
$2.02M -$14.6K -1,278 -0.8%
Swiss National Bank
50
Swiss National Bank
Switzerland
$1.97M +$43.7K +3,821 +3%
1
2
3 4 5

IRWD Hedge Fund Activity: Q4 2014 in Review

129 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q4 2014, worth a combined $2.05B — up 20% from $1.71B a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of IRWD and 10 opened new positions — a net loss of 9 holders — while 42 trimmed existing stakes and 45 added.

The largest buyer was Deutsche Bank, adding an estimated $22.6M. The largest seller was State of Wisconsin Investment Board, cutting an estimated $15.6M.

  • 129 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q4 2014, down from 140 in Q3 2014.
  • Funds reported $2.05B of Ironwood Pharmaceuticals stock for Q4 2014, up 20% quarter-over-quarter.
  • 10 funds opened new Ironwood Pharmaceuticals positions in Q4 2014 and 19 closed out, a net change of -9 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q4 2014 was Deutsche Bank, an estimated $22.6M added.
  • The largest Ironwood Pharmaceuticals seller in Q4 2014 was State of Wisconsin Investment Board, an estimated $15.6M sold.

Based on aggregated 13F filings for Q4 2014.